QuiVad

Home / Netherlands / Lakefront Biotherapeutics NV

Lakefront Biotherapeutics NV

No short position is open on this share today.

Follow

Evolution of the disclosed total

0%1%2%3%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
The whole history, peaking at 6.24% on October 25, 2019. The shaded band is the year shown above.

July 31, 2015 today

Open positions

No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.

History of disclosures

689 disclosures on record for this share.
DateFund% of capitalEnd of publication
April 2, 2026Arrowstreet Capital, Limited Partnership0.48%still open
March 30, 2026Arrowstreet Capital, Limited Partnership0.58%still open
March 24, 2026Arrowstreet Capital, Limited Partnership0.69%still open
March 13, 2026Arrowstreet Capital, Limited Partnership0.77%still open
March 6, 2026Arrowstreet Capital, Limited Partnership0.89%still open
March 2, 2026Arrowstreet Capital, Limited Partnership0.98%still open
February 26, 2026Arrowstreet Capital, Limited Partnership1.05%still open
February 4, 2026Arrowstreet Capital, Limited Partnership1.19%still open
January 21, 2026Arrowstreet Capital, Limited Partnership1.29%still open
January 15, 2026Arrowstreet Capital, Limited Partnership1.38%still open
January 7, 2026Arrowstreet Capital, Limited Partnership1.49%still open
December 22, 2025Qube Research & Technologies Ltd.0.49%still open
December 18, 2025Qube Research & Technologies Ltd.0.50%still open
December 11, 2025Qube Research & Technologies Ltd.0.49%still open
October 24, 2025Qube Research & Technologies Ltd.0.59%still open
October 21, 2025Qube Research & Technologies Ltd.0.60%still open
October 15, 2025Arrowstreet Capital, Limited Partnership1.59%still open
August 26, 2025Millennium International Management LP0.29%still open
August 25, 2025Qube Research & Technologies Ltd.0.59%still open
August 22, 2025Millennium International Management LP0.50%still open
August 19, 2025Arrowstreet Capital, Limited Partnership1.69%still open
July 31, 2025Arrowstreet Capital, Limited Partnership1.79%still open
July 24, 2025Qube Research & Technologies Ltd.0.67%still open
July 17, 2025Citadel Advisors LLC0.48%still open
July 15, 2025Qube Research & Technologies Ltd.0.57%still open
July 9, 2025Citadel Advisors LLC0.58%still open
July 2, 2025Arrowstreet Capital, Limited Partnership1.80%still open
June 20, 2025Arrowstreet Capital, Limited Partnership1.71%still open
June 6, 2025Citadel Advisors LLC0.69%still open
May 28, 2025Arrowstreet Capital, Limited Partnership1.60%still open
May 22, 2025Citadel Advisors LLC0.71%still open
May 20, 2025Citadel Advisors LLC0.66%still open
May 20, 2025Qube Research & Technologies Ltd.0.61%still open
May 19, 2025Arrowstreet Capital, Limited Partnership1.53%still open
May 15, 2025Arrowstreet Capital, Limited Partnership1.43%still open
May 13, 2025Citadel Advisors LLC0.72%still open
May 9, 2025Arrowstreet Capital, Limited Partnership1.31%still open
May 7, 2025Citadel Advisors LLC0.67%still open
May 6, 2025Arrowstreet Capital, Limited Partnership1.20%still open
May 6, 2025Citadel Advisors LLC0.70%still open
April 30, 2025Arrowstreet Capital, Limited Partnership1.13%still open
April 25, 2025Qube Research & Technologies Ltd.0.51%still open
April 23, 2025Arrowstreet Capital, Limited Partnership1.01%still open
April 15, 2025Citadel Advisors LLC0.64%still open
April 14, 2025Citadel Advisors LLC0.58%still open
April 14, 2025Marshall Wace LLP0.49%still open
April 14, 2025Qube Research & Technologies Ltd.0.48%still open
April 7, 2025Qube Research & Technologies Ltd.0.50%still open
April 4, 2025Arrowstreet Capital, Limited Partnership0.90%still open
April 3, 2025Citadel Advisors LLC0.60%still open

Other companies sold short in the Netherlands

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Lakefront Biotherapeutics NV, source AFM, data as at April 2, 2026, https://www.quivad.com/action/lakefront-biotherapeutics-nv